Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 8 Dec 2025
- Closes
- 6 Mar 2027, 23:59 UTC
- Value
- USD 500,000
- Reference
- PAR-26-116
- Location
- United States
- Sector
- Healthcare & Pharma
At a glance
National Institutes of Health in United States has published a funding call in healthcare & pharma: “Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)”. Submissions close on 6 March 2027, 118 days from today. The stated value is USD 500,000. Quote reference PAR-26-116 in any correspondence with the buyer. FreeTender has recorded 458 notices from this buyer since 2023, 380 of them currently open. There are 395 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through Grants.gov — US federal funding opportunities, not through FreeTender.
Key requirements
Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.
To bid on Grants.gov (US federal)
Applicants need a UEI from SAM.gov and a Grants.gov account registered to their organisation; allow several weeks for registration.
Details
The goal of this program is to support collaborative translational research projects aligned with NIH efforts to enhance the translation of basic biological discoveries into clinical applications that improve health. It encourages high quality science demonstrating the potential to result in understanding an important disease process or lead to new therapeutic interventions, diagnostics, or prevention strategies within the research interests and priorities of the participating NIH Institutes/Centers (ICs).Specifically, the program seeks to broaden and strengthen translational research collaborations between basic and clinical researchers both within and outside NIH to accelerate and enhance translational science by promoting partnerships between NIH intramural investigators (e.g., those conducting research within the labs and clinics of the NIH) and extramural investigators (e.g., those conducting research in labs outside the NIH), and by providing support for extramural investigators to take advantage of the unique research opportunities available at the NIH Clinical Center by conducting clinical research projects in collaboration with NIH intramural investigators. Eligibility: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. This new requirement was effective, May 1, 2025.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.
CFDA number(s): 93.313
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 458 notices from National Institutes of Health, going back to May 2023 — 380 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 395 open Healthcare & Pharma tenders in United States. This one closes in 118 days.
More from this buyer
- NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)· closes 20 Feb
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)· closes 17 Feb
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)· closes 5 Mar
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)· closes 5 Mar
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)· closes 1 Feb
Similar Healthcare & Pharma tenders
- Research Grants Supporting Scientific Discovery, Academic Research and New Studies· closes 18 Jan
- Stopper, Bottle — Laboratory Equipment and Supplies· closes 7 Dec
- Region IX Emergency Medical Membership Access· closes 4 Dec
- OCONUS Medical Q-Coded Services — General Health Care Services· closes 19 Apr
- Women's Initiative for Screening and Health (WISH)· closes 8 Jan
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Поставка лекарственного препарата (Тестостерон) для индивидуального обеспечения граждан, имеющих право на получение государственной социальной помощи в городе Москве (УНЗ: Z271906 - Д)ФИЛИАЛ № 1 ГКУ "АЗ (КС) ДЗМ" · Russia
- Поставка лекарственного препарата Ацетилсалициловая кислотаМИНИСТЕРСТВО ИМУЩЕСТВЕННЫХ ОТНОШЕНИЙ И ГОСУДАРСТВЕННОГО ЗАКАЗА ТАМБОВСКОЙ ОБЛАСТИ · Russia
- Электронный аукцион на поставку растворов для промывания ран для нужд операционного блока ГБУЗ «ГКБ № 29 им. Н.Э. Баумана ДЗМ»ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ ГОРОДА МОСКВЫ "ГОРОДСКАЯ КЛИНИЧЕСКАЯ БОЛЬНИЦА № 29 ИМ. Н.Э. БАУМАНА ДЕПАРТАМЕНТА ЗДРАВООХРАНЕНИЯ ГОРОДА МОСКВЫ" · Russia
- Поставка лекарственных средств (лот7) для нужд СПб ГКУЗ "ГПБ №6" в 2027 годуСАНКТ-ПЕТЕРБУРГСКОЕ ГОСУДАРСТВЕННОЕ КАЗЕННОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ "ГОРОДСКАЯ ПСИХИАТРИЧЕСКАЯ БОЛЬНИЦА № 6 (СТАЦИОНАР С ДИСПАНСЕРОМ)" · Russia
- Поставка лекарственных средств (МНН – Брекспипразол таблетки, покрытые оболочкой 1 мг, 3мг) для нужд ГБУЗ «ПКБ № 1 ДЗМ» в 2027 годуГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ ГОРОДА МОСКВЫ "ПСИХИАТРИЧЕСКАЯ КЛИНИЧЕСКАЯ БОЛЬНИЦА № 1 ИМ. Н. А. АЛЕКСЕЕВА ДЕПАРТАМЕНТА ЗДРАВООХРАНЕНИЯ ГОРОДА МОСКВЫ" · Russia
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →